Ian Li has extensive experience in investment and board roles, presently serving as Principal at 1315 Capital since April 2015, where previous positions included Vice President and Senior Associate. Li is also active on the boards of several companies, including CortiCare, 3B Scientific, miraDry, Inc., Colorescience, and NutriSense, along with a past board observer role at Bonafide Health and CHC Solutions, Inc. Li's experience includes a consulting role at Capgemini Consulting prior to joining 1315 Capital. Ian Li holds a Bachelor of Science in Engineering with concentrations in Biomedical Engineering and Economics from Duke University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices